Tony W. Ho, Executive VP, Head of R&D at CRISPR Therapeutics AG (CRSP), sold 29,602 shares at $150.61 ($4.4M) on 2020-12-21, disclosed to the SEC on 2020-12-22.
Open-market sale of $4.4M CRSP by Executive VP, Head of R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $147.05 | 1,400 | $206K | 4.7% |
| 2 | $147.05 | 1,400 | $206K | 4.7% |
| 3 | $148.11 | 1,700 | $252K | 5.7% |
| 4 | $148.11 | 1,700 | $252K | 5.7% |
| 5 | $148.38 | 8,400 | $1.2M | 28.2% |
| 6 | $149.18 | 900 |
| $134K |
| 3.0% |
| 7 | $149.73 | 5,000 | $749K | 17.0% |
| 8 | $150.16 | 1,600 | $240K | 5.4% |
| 9 | $150.61 | 2,951 | $444K | 10.1% |
| 10 | $150.61 | 2,951 | $444K | 10.1% |
| 11 | $151.58 | 1,100 | $167K | 3.8% |
| 12 | $152.41 | 500 | $76K | 1.7% |
| Total | $149.20 avg | 29,602 | $4.4M | 100% |
| Filing → |